These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8649659)

  • 21. Neurohumoral responses to a single haemodialysis in chronic renal patients.
    Uusimaa P; Huttunen K; Ruskoaho H; Linnaluoto M; Ikäheimo M
    Acta Physiol Scand; 1999 Jan; 165(1):25-31. PubMed ID: 10072093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of the femoral artery route for placement of temporary catheters for emergency haemodialysis when all usual central venous access sites are exhausted.
    Frampton AE; Kessaris N; Hossain M; Morsy M; Chemla ES
    Nephrol Dial Transplant; 2009 Mar; 24(3):913-8. PubMed ID: 18952702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function.
    Korsheed S; Eldehni MT; John SG; Fluck RJ; McIntyre CW
    Nephrol Dial Transplant; 2011 Oct; 26(10):3296-302. PubMed ID: 21317408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of erythropoietin treatment on plasma renin activity, aldosterone, vasopressin and atrial natriuretic peptide in haemodialyzed patients.
    Kokot F; Wiecek A; Grzeszczak W; Klin M
    Miner Electrolyte Metab; 1990; 16(1):25-9. PubMed ID: 2139159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis.
    Zilch O; Vos PF; Oey PL; Cramer MJ; Ligtenberg G; Koomans HA; Blankestijn PJ
    J Hypertens; 2007 Jun; 25(6):1285-9. PubMed ID: 17563543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between vasoactive substances and changes in blood pressure during hemodialysis].
    Takahashi M
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):549-57. PubMed ID: 7474507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arteriovenous access closure in hemodialysis patients with refractory heart failure: a single center experience.
    Kurita N; Mise N; Tanaka S; Tanaka M; Sai K; Nishi T; Miura S; Kigawa I; Miyairi T; Sugimoto T
    Ther Apher Dial; 2011 Apr; 15(2):195-202. PubMed ID: 21426513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Different cardiovascular and hormonal consequences of A-V fistula in uremic patients (author's transl)].
    Pinelli G; Longhini C; Portaluppi F; Manini GL; Dominici P; Zuccalà A; Santoro A; Degli Esposti E
    G Ital Cardiol; 1980; 10(5):598-604. PubMed ID: 7004989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endothelin in patients with chronic kidney failure].
    Nĕmecek K; Bártová V; Jáchymová M; Horký K
    Cas Lek Cesk; 1995 Aug; 134(16):511-3. PubMed ID: 7553749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide.
    Raine AE; Bock A; Muller FB; Erne P; Bolli P; Brunner F; Buhler FR
    Nephrol Dial Transplant; 1989; 4(3):222-7. PubMed ID: 2524680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of an arteriovenous access for hemodialysis to left ventricular hypertrophy.
    Ori Y; Korzets A; Katz M; Erman A; Weinstein T; Malachi T; Gafter U
    Am J Kidney Dis; 2002 Oct; 40(4):745-52. PubMed ID: 12324909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamic abnormalities in different kind of arteriovenous access for hemodialysis].
    Sedov VM; Alferov SV; Karpov SA; Grinev KM
    Vestn Khir Im I I Grek; 2013; 172(4):44-8. PubMed ID: 24341244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.
    de Châtel R; Makó J; Tóth M; Barna I; Lang RE
    Int Urol Nephrol; 1991; 23(2):177-83. PubMed ID: 1830872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised controlled trial of buttonhole cannulation for the prevention of fistula access complications.
    Chow J; Rayment G; San Miguel S; Gilbert M
    J Ren Care; 2011 Jun; 37(2):85-93. PubMed ID: 21561544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic and atrial natriuretic peptide responses to fluid removal and reinfusion in hemodialysis patients.
    Petersen J; Li CC; Bishop-Abney N; Seniw CM
    ASAIO Trans; 1988; 34(3):509-11. PubMed ID: 2973791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of arteriovenous fistula formation on central hemodynamic pressures in chronic renal failure patients: a prospective study.
    Savage MT; Ferro CJ; Sassano A; Tomson CR
    Am J Kidney Dis; 2002 Oct; 40(4):753-9. PubMed ID: 12324910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis.
    Plum J; Grabensee B
    J Intern Med; 1991 Mar; 229(3):209-16. PubMed ID: 1826125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-output cardiac failure due to excessive shunting in a hemodialysis access fistula: an easily overlooked diagnosis.
    Engelberts I; Tordoir JH; Boon ES; Schreij G
    Am J Nephrol; 1995; 15(4):323-6. PubMed ID: 7573191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlates of atrial natriuretic factor in chronic renal failure.
    Tonolo G; Soro A; Scardaccio V; Troffa C; Pazzola A; Manunta P; Melis MG; Pala F; Madeddu P; Rovasio PP
    J Hypertens Suppl; 1989 Dec; 7(6):S238-9. PubMed ID: 2534409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Change in haemoglobin concentration, haematocrit and vasoactive hormones in haemodialysis patients with erythropoietin-associated hypertension.
    Sasagawa I; Nakada T; Hashimoto T; Kubota Y; Suzuki H; Sawamura T
    Int Urol Nephrol; 1994; 26(2):237-43. PubMed ID: 8034437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.